Transposable elements may enhance antiviral resistance in HIV-1 elite controllers

被引:0
|
作者
Singh, Manvendra [1 ,4 ]
Leddy, Sabrina M. [1 ]
Iniguez, Luis Pedro [2 ]
Bendall, Matthew L. [3 ]
Nixon, Douglas F. [3 ,5 ]
Feschotte, Cedric [1 ]
机构
[1] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA
[2] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain
[3] Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA
[4] Max Planck Inst Multidisciplinary Sci, Clin Neurosci, City Campus, Gottingen, Germany
[5] Feinstein Inst Med Res, Manhasset, NY 11030 USA
来源
GENOME BIOLOGY | 2025年 / 26卷 / 01期
关键词
Genomics; HIV; Retroviruses; Immunology; Gene regulation; Transposable elements; INNATE IMMUNITY; EVOLUTION; PROTEIN; GENES; DNA; ACTIVATION; INFECTION; APOBEC3G; TRANSCRIPTION; DETERMINANTS;
D O I
10.1186/s13059-025-03484-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundLess than 0.5% of people living with HIV-1 are elite controllers (ECs)-individuals who maintain undetectable plasma viremia without antiretroviral therapy, despite having replication-competent viral reservoirs. While EC CD4+ T cells have been investigated for gene expression signatures associated with HIV-1 resistance, the expression and regulatory activity of transposable elements (TEs) remain unexplored. TEs can directly impact host immune responses to pathogens, including HIV-1, suggesting their activities could contribute to HIV-1 elite control. To begin testing this hypothesis, we conduct a TE-centric analysis of public multi-omics data from ECs and other populations.ResultsWe find the CD4+ T cell transcriptome and retrotranscriptome of ECs are distinct from healthy controls, from people living with HIV-1 on antiretroviral therapy, and from viremic progressors. However, there is substantial transcriptomic heterogeneity among ECs. We categorize ECs into four clusters with distinct expression and chromatin accessibility profiles of TEs and antiviral factors. Several TE families with known immuno-regulatory activity are differentially expressed among ECs. Their expression positively correlates with their chromatin accessibility in ECs and negatively correlates with the expression of their KRAB zinc-finger (KZNF) repressors. This coordinated, locus-level variation forms a network of putative cis-regulatory elements for genes involved in HIV-1 restriction.ConclusionsWe propose that the EC phenotype is driven in part by reduced KZNF-mediated repression of specific TE-derived cis-regulatory elements for antiviral genes, heightening their resistance against HIV-1. Our study reveals heterogeneity in the EC CD4+ T cell transcriptome, including variable expression of TEs and their KZNF controllers, that must be considered when deciphering HIV-1 control mechanisms.
引用
收藏
页数:29
相关论文
共 50 条
  • [31] The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?
    Blankson, Joel
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (03) : 147 - 150
  • [32] Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
    Casado, Concepcion
    Galvez, Cristina
    Pernas, Maria
    Tarancon-Diez, Laura
    Rodriguez, Carmen
    Sanchez-Merino, Victor
    Vera, Mar
    Olivares, Isabel
    De Pablo-Bernal, Rebeca
    Merino-Mansilla, Alberto
    Del Romero, Jorge
    Lorenzo-Redondo, Ramon
    Ruiz-Mateos, Ezequiel
    Salgado, Maria
    Martinez-Picado, Javier
    Lopez-Galindez, Cecilio
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] CD4 T-cell regeneration in HIV-1 elite controllers
    Yang, Yue
    Al-Mozaini, Maha
    Buzon, Maria J.
    Beamon, Jill
    Ferrando-Martinez, Sara
    Ruiz-Mateos, Ezequiel
    Rosenberg, Eric S.
    Pereyra, Florencia
    Yu, Xu G.
    Lichterfeld, Mathias
    AIDS, 2012, 26 (06) : 701 - 706
  • [34] Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers
    Lian, Xiaodong
    Gao, Ce
    Sun, Xiaoming
    Jiang, Chenyang
    Einkauf, Kevin B.
    Seiger, Kyra W.
    Chevalier, Joshua M.
    Yuki, Yuko
    Martin, Maureen
    Hoh, Rebecca
    Peluso, Michael J.
    Carrington, Mary
    Ruiz-Mateos, Ezequiel
    Deeks, Steven G.
    Rosenberg, Eric S.
    Walker, Bruce D.
    Lichterfeld, Mathias
    Yu, Xu G.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (624)
  • [35] Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers
    Walker, Wendy E.
    Kurscheid, Sebastian
    Joshi, Samit
    Lopez, Charlie A.
    Goh, Gerald
    Choi, Murim
    Barakat, Lydia
    Francis, John
    Fisher, Ann
    Kozal, Michael
    Zapata, Heidi
    Shaw, Albert
    Lifton, Richard
    Sutton, Richard E.
    Fikrig, Erol
    JOURNAL OF VIROLOGY, 2015, 89 (10) : 5502 - 5514
  • [36] Persistent Low-Level Viremia in HIV-1 Elite Controllers and Relationship to Immunologic Parameters
    Pereyra, Florencia
    Palmer, Sarah
    Miura, Toshiyuki
    Block, Brian L.
    Wiegand, Ann
    Rothchild, Alissa C.
    Baker, Brett
    Rosenberg, Rachel
    Cutrell, Emily
    Seaman, Michael S.
    Coffin, John M.
    Walker, Bruce D.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (06): : 984 - 990
  • [37] Prevalence of HIV-1 Dual Infection in Long-Term Nonprogressor-Elite Controllers
    Pernas, Maria
    Casado, Concepcion
    Sandonis, Virginia
    Arcones, Carolina
    Rodriguez, Carmen
    Ruiz-Mateos, Ezequiel
    de Arellano, Eva Ramirez
    Rallon, Norma
    Del Val, Margarita
    Grau, Eulalia
    Lopez-Vazquez, Mariola
    Leal, Manuel
    Del Romero, Jorge
    Lopez Galindez, Cecilio
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (03) : 225 - 231
  • [38] Elite Suppression of HIV-1 Replication
    Blankson, Joel N.
    Siliciano, Robert F.
    IMMUNITY, 2008, 29 (06) : 845 - 847
  • [39] Genetic analyses suggest functional differences in the nature of persistent viraemia between HIV-1 elite controllers and therapy exposed controllers
    Mens, H.
    Kearney, M.
    Wiegand, A.
    Schonning, K.
    Gerstoft, J.
    Obel, N.
    Maldarelli, F.
    Mellors, J. W.
    Benfield, T.
    Coffin, J. M.
    ANTIVIRAL THERAPY, 2010, 15 : A171 - A171
  • [40] A Distinct Treg Transcriptome Signature in HIV-1 Elite Controllers Might Contribute to Improved Disease Outcome
    Dahlke, Christine
    Angin, Mathieu
    Mueller, Christian
    Sharma, Siddharta
    Bhasin, Manoj K.
    Zhuang, Yan
    Addo, Marylyn M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A180 - A180